Innovative Health Product Company Launches Luxury Sunscreen Free of Harmful Chemicals

COLUMBUS, OH--(Marketwire - March 2, 2009) - A.I. Specialty Healthcare Ltd., an innovative leading health and lifestyle product development company, is pleased to announce the launch of its medically safe, chemical free sunblock, Azur® Advanced Pro-Cellular Sunscreen.

Azur® is the first chemically inert non-endocrine disrupting natural sunscreen designed to protect sun lovers, children and those concerned with their health, against the harmful rays of the sun without the additional long-term risk of cancer from the sunscreen itself.

Conventional sunscreens contain ingredients that may interfere with the body's normal hormone functioning. Growing evidence suggests that those ingredients can mimic estrogen or testosterone and pose a risk of breast or prostate cancer, and possibly even reproductive problems in children whose bodies are still developing. Eliminating those ingredients allows the endocrine system to function the way nature intended.

Azur® sunscreen contains natural, mineral-based ingredients that provide instant protection against UVA, UVB and the little known UVC wavelengths. Based on the most current data, Azur® keeps skin cells healthy and does not contain any ingredients that negatively affect the body's chemistry. Its active ingredients form a physical barrier from the sun's rays, while none of the product's ingredients break down on the skin or generate an abnormal endocrine system response.

"There are potentially damaging chemicals found in nearly 600 sunscreens on the market today which can potentially cause serious health problems for consumers, especially young children," said Joseph J. Pinzone, MD, MBA, Medical Director for A.I. Specialty Healthcare. "Many consumers are unaware that 84% of sunscreens either contain potentially toxic endocrine disruptors like oxybenzone or do not provide adequate protection from the sun. Consumers concerned with healthy living now have a product with Azur® Advanced Pro-Cellular Sunscreen that they can really trust, and is luxurious and pleasing to the senses."

Dr. Pinzone references research conducted by the Centers for Disease Control and Prevention (CDC) and the Environmental Working Group (EWG), a nonprofit research organization based in Washington, DC. Recently, EWG discovered that the Food and Drug Administration (FDA) does not require cosmetic companies to specifically disclose that their products include endocrine disruptors. Visit www.azurskin.com for additional product information as well as news and information on endocrine disruption.

In addition to UV protection, regular use of Azur® provides the skin with important anti-oxidant vitamins A, C and E and natural sunscreen agents, titanium dioxide and zinc oxide. Importantly, Azur® is rated as "Very Water Resistant" which means it goes on and stays on, enhancing its effectiveness and protection.

Azur® has already established a loyal fan base of consumers including celebrities, athletes and health enthusiasts. Azur® is available for face and body in SPF 30 and 40; the four-ounce package retails for $18.99. Azur® is not available in stores, but can be purchased online at www.azurskin.com.

About A.I. Specialty Healthcare Ltd.

Founded in 2006, A.I. Specialty Healthcare Ltd. promotes products that take advantage of the latest medical and scientific information and technology for safe and effective health-related products in the 21st Century. A.I. is focused on identifying and commercializing innovative products for the global marketplace that promote positive and healthy living. A.I.'s most recent product currently on the market is Azur® Advanced Pro-Cellular Sunscreen. Through the Azur® product line, A.I. is educating consumers about the potential dangers of cancer as a result of exposure to endocrine disruptors from common sunscreen active ingredients. For more information, visit www.azurskin.com.

Contact Information: Contact: Kristin Mack Deuber Senior Account Supervisor Paul Werth Associates 614-224-8114 Brynn Burton Senior Account Executive Paul Werth Associates 614-224-8114 Joseph J. Pinzone, MD, MBA Medical Director A.I. Specialty Healthcare 614-899-2110